The Global Vaccine Data Network (GVDN) is gearing up to be able to collaboratively assess the safety of COVID-19 vaccines once they have been introduced. Part of this work involves collecting information about background rates of potential Adverse Events of Special Interest (AESI) i.e. medical conditions that may be related to vaccinations. Fears about AESIs often don’t take account of background rates.
Recent Posts
- New Zealand takes first steps to monitor the safety of COVID-19 vaccines February 18, 2021
- As Millions Get Shots in USA, the F.D.A. Struggles to Get Safety Monitoring System Running February 15, 2021
- Understanding mRNA COVID-19 Vaccines January 11, 2021
- Ensuring safety of COVID-19 vaccines November 26, 2020
- Will it be safe? Vaccine safety science from the Cow Pock to COVID-19 November 25, 2020
Recent Comments